Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02605174
Brief Title: Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine (SPARTAN)

First Submitted : November 11, 2015
First Submitted that Met QC Criteria : November 12, 2015
First Posted : November 16, 2015 (Estimate)

Results First Submitted : June 28, 2018
Results First Submitted that Met QC Criteria : June 28, 2018
Results First Posted : July 30, 2018

Last Update Submitted that Met QC Criteria : September 5, 2019
Last Update Posted : September 23, 2019